London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.

Safety outcomes of an investigational angle-supported phakic lens for moderate to high myopia: 5 year results for second eyes

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Posterior chamber Phakic IOLS for correction of Myopia

Session Date/Time: Monday 15/09/2014 | 08:00-10:30

Paper Time: 09:11

Venue: Capital Hall B

First Author: : A.Maxwell USA

Co Author(s): :                  

Abstract Details


To assess long term safety outcomes of an angle-supported phakic lens for the correction of moderate to high myopia


3 open-label trials in U.S. (C-02-23), Europe (C-02-40), and Canada (C-02-21).


In a prospective, integrated analyses at 5 years: 360 subjects (>18 years of age) underwent implantation of an AcrySof Cachet Phakic Lens. Study exclusions were previous corneal or ocular surgery, history of glaucoma, any type of cataract, >2.0 D of preoperative corneal astigmatism, and mesopic pupil size >7.0 mm. Second-eye outcomes at 5 years postoperative included mean annualized percentage change in endothelial and peripheral cell density (ECD) since the 6 month postoperative visit and cumulative serious adverse events (out of 155 operations).


Mean annualized percentage change (± standard deviation) in central ECD was 1.6±2.1% (n=87; range, -14.4% to 2.5%). Mean annualized percentage change (± standard deviation) in peripheral ECD was -1.8±2.6% (n=87; range, -15% to 3.2%). Serious adverse events did not include IOL related secondary surgical intervention (0/155), but did include synechia (6/155), cataract formation (1/155), and pupil ovalization greater than 1.0 mm (1/155).


Safety outcomes assessed at 5 years postoperative to second-eye implantation of the investigational AcrySof Cachet Phakic Lens revealed promising safety outcomes and ECD changes within acceptable limits.

Financial Interest:

One or more of the authors... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, One or more of the authors... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to previous